Berkshire Capital Holdings’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
32,880
+32,870
+328,700% +$8.72M 3.44% 13
2026
Q1
$1.1K Sell
10
-87,920
-100% -$12.5M ﹤0.01% 74
2025
Q4
$14.6M Buy
87,930
+87,920
+879,200% +$14.7M 4.85% 8
2025
Q3
$1.96K Hold
10
– – ﹤0.01% 57
2025
Q2
$904 Hold
10
– – ﹤0.01% 75
2025
Q1
$597 Sell
10
-121,340
-100% -$11.2M ﹤0.01% 76
2024
Q4
$16.1M Buy
+121,350
New +$11.4M 5.81% 6

Other funds holding ALAB

Berkshire Capital Holdings's ALAB Position: Q2 2026 in Review

Berkshire Capital Holdings increased its Astera Labs (ALAB) stake by 328,700% in Q2 2026, buying an estimated $8.72M and bringing the position to 32,880 shares worth $15.9M. The position accounts for 3.44% of the portfolio, ranked #13.

Berkshire Capital Holdings first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.1M in Q4 2024. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Berkshire Capital Holdings held 32,880 shares of Astera Labs worth $15.9M as of Q2 2026.
  • Berkshire Capital Holdings bought 32,870 Astera Labs shares in Q2 2026, an estimated $8.72M.
  • Astera Labs made up 3.44% of Berkshire Capital Holdings's portfolio in Q2 2026, its #13 holding.
  • Berkshire Capital Holdings first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • Berkshire Capital Holdings's Astera Labs position peaked at $16.1M in Q4 2024.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Berkshire Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.